FDA Import Refusal W47-0058431-7/1/1 — Xellia Pharmaceuticals ApS
The FDA refused shipment W47-0058431-7/1/1 from Xellia Pharmaceuticals ApS (Denmark) on February 19, 2014. The refused product falls under Drugs and Biologics — POLYMYXIN B SULFATE (PEPTIDES). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- February 19, 2014
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 56FBK30 POLYMYXIN B SULFATE (PEPTIDES)
- Charges
- 75